Paclitaxel-Cisplatinum in treatment of metastatic breast cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F99%3A00000038" target="_blank" >RIV/00209805:_____/99:00000038 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Paclitaxel-Cisplatinum in treatment of metastatic breast cancer
Original language description
Paclitaxel can be used in combination with common cytostatics. The combination of paclitaxel and cisplatin is very effective regimen in pretreated patients with generalized breast cancer including patients with the resistance to anthracyclines.
Czech name
—
Czech description
—
Classification
Type
D - Article in proceedings
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
1999
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Article name in the collection
9th International Congress on Anti-Cancer Treatment
ISBN
—
ISSN
—
e-ISSN
—
Number of pages
1
Pages from-to
—
Publisher name
Neuv.
Place of publication
Paris
Event location
—
Event date
—
Type of event by nationality
—
UT code for WoS article
—